These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 29517104

  • 1. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
    Wu S, Ai N, Liu Q, Zhang J.
    Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
    Song D, Diao J, Yang Y, Chen Y.
    Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y, Liang G, Wang H, Liu Z.
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA‑330 is downregulated in retinoblastoma and suppresses cell viability and invasion by directly targeting ROCK1.
    Wang L, Wang L, Li L, Zhang H, Lyu X.
    Mol Med Rep; 2019 Oct; 20(4):3440-3447. PubMed ID: 31432120
    [Abstract] [Full Text] [Related]

  • 5. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.
    Huang Y, Xue B, Pan J, Shen N.
    Exp Mol Pathol; 2021 Jun; 120():104637. PubMed ID: 33844975
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a.
    Lyu X, Wang L, Lu J, Zhang H, Wang L.
    Oncol Rep; 2019 May; 41(5):3137-3147. PubMed ID: 30896857
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
    Huang YX, Nie XG, Li GD, Fan DS, Song LL, Zhang XL.
    Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. miR-29a inhibits human retinoblastoma progression by targeting STAT3.
    Liu S, Zhang X, Hu C, Wang Y, Xu C.
    Oncol Rep; 2018 Feb; 39(2):739-746. PubMed ID: 29251322
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN.
    Wei D, Miao Y, Yu L, Wang D, Wang Y.
    Mol Med Rep; 2018 Jul; 18(1):595-602. PubMed ID: 29749457
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin.
    Zhang Y, Wang X, Zhao Y.
    Mol Med Rep; 2018 Sep; 18(3):3099-3105. PubMed ID: 30015932
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
    Liu F, Zhang Q, Liang Y.
    J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
    [Abstract] [Full Text] [Related]

  • 16. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.
    Wang J, Wang S, Chen L, Tan J.
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA‑758 inhibits malignant progression of retinoblastoma by directly targeting PAX6.
    Li J, You X.
    Oncol Rep; 2018 Sep; 40(3):1777-1786. PubMed ID: 30015924
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
    Zhao J, Li Z, Chen Y, Zhang S, Guo L, Gao B, Jiang Y, Tian W, Hao S, Zhang X.
    Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.